Forbes December 8, 2024
John Werner

In some of the most interesting use cases for artificial intelligence, the digital processes are applied to a physical supply chain.

At MIT’s Engine, an incubator and co-working space with many teams working on various inventions, Ashley Beckwith does research for a startup called Foray Bioscience, with the goal of disrupting conventional manufacturing of wood products, and pursuing targeted reforestation.

Estimating that the world has lost a half million acres of forest in the last quarter of a century, Foray is looking at the possibility of getting live cells from plants to develop synthetic products.

Beckwith is pursuing cell culture and tissue engineering: in a recent Planet Action presentation, she talked about how to envision and then tackle the problem.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Will Trump Drug Tariffs Help Or Hurt The U.S.?
Medicare Coverage Of Medical Technologies In A New Era
A Bright Future for AI in Pharma
GenAI and the revolution of drug development
Amgen starts two critical late-stage trials for weight loss drug MariTide

Share This Article